SymbolFOXO
NameFOXO TECHNOLOGIES INC.
SectorUNDEFINED
RegionNorth America
Industry-
Address33401 United States FL 477 South Rosemary Avenue Suite 224
Telephone(612)800-0059
Fax
Email
Websitehttps://foxotechnologies.com/
IncorporationUS
Incorporated On2020
Employees
Fiscal Year12/31
Public Since
ExchangesOTC;OTCID;NASDAQ
AuditorKreit & Chiu;
Audit StatusAUDITED
Reporting StatusU.S. Reporting: SEC Reporting
CIK0001812360
Description

FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report.

Additional info from OTC:
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report.

Additional info from OTCID:
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report.

2026-07-29 12:30

FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.

Read more
2026-07-06 13:07

FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS

Read more
2026-07-01 11:30

FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT

Read more
2026-05-28 12:33

FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY

Read more
2026-02-12 08:05

New Form EFFECT - FOXO TECHNOLOGIES INC. <b>Filed:</b> 2026-02-11 <b>AccNo:</b> 9999999995-26-000541 <b>Size:</b> 1 KB

Read more
2026-02-11 18:23

New Form 424B3 - FOXO TECHNOLOGIES INC. <b>Filed:</b> 2026-02-11 <b>AccNo:</b> 0001493152-26-006208 <b>Size:</b> 348 KB

Read more
2026-02-06 22:05

(10% Negative) Foxo Technologies Inc (FOXO) Announces Business Combination

Read more
2026-01-21 13:06

New Form SCHEDULE 13G - FOXO TECHNOLOGIES INC. Filed: 2026-01-21 AccNo: 0001535610-26-000014 Size: 9 KB

Read more
2026-01-20 22:10

(64% Neutral) Foxo Technologies Inc (FOXO) Provides Update on coverage for cardiology

Read more
2025-12-29 22:21

New Form DEF 14C - FOXO TECHNOLOGIES INC. Filed: 2025-12-29 AccNo: 0001493152-25-029439 Size: 825 KB

Read more